Tous les communiqués | WebDisclosure

Switch to English

10411	Sociétés
217790	Mots-clés
147338	Articles
115238	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:30, il y a 1 année 6 mois

XS Financial Expands Into Middle-Market Equipment Finance, Establishing Buy-Side Capital Markets Desk
XS Financial announces strategic expansion into mid to large-ticket transactions in middle-market equipment leasing sector. Acquired by Axar and Mavik, enhancing financial strength and flexibility

Expansion Capital Markets Equipment Finance XS Financial Middle-Market
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:30, il y a 1 année 6 mois

LQR House Inc. Implements Strategic Cost-Cutting Measures Under Activist Investor David Lazar's Leadership
LQR House Inc. announces strategic updates including shutting down RareSips NFT platform and ending Bevage LLC partnership under new Director David Lazar to enhance operational efficiency and shareholder value

LQR House Inc. Operational Efficiency Shareholder Value Strategic Updates David Lazar
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:30, il y a 1 année 6 mois

Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
Catheter Precision announces publication on non-invasive ablation technique STAR for cardiac electrophysiology. VIVO technology shows promising results in targeting heart arrhythmia areas

Catheter Precision Cardiac Electrophysiology VIVO Technology STAR Ablation Technique
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:30, il y a 1 année 6 mois

Inventiva annonce un abstract « late breaker » sur l’essai clinique de Phase 2, LEGEND, combinant lanifibranor et empagliflozine, lors du Liver Meeting™ 2024 organisé par l’AASLD
Inventiva annonce un abstract "late breaker" sur l'essai clinique de Phase 2, LEGEND, combinant lanifibranor et empagliflozine lors du Liver Meeting™ 2024 organisé par l'AASLD

Essai Clinique Inventiva Lanifibranor Abstract Empagliflozine
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:30, il y a 1 année 6 mois

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:25, il y a 1 année 6 mois

Director/PDMR Shareholding
Britvic plc Directors purchase shares and receive matching shares under Share Incentive Plan. Details of transactions and interests disclosed

Transactions Share Incentive Plan Britvic Plc Directors Matching Shares
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:15, il y a 1 année 6 mois

Quant Tekel: Defining the Future of Trading
Quant Tekel revolutionizes brokerage and prop trading with cutting-edge technology, unmatched experience, and top-tier support for traders, offering opportunities for success and personal growth

Cutting-edge Technology Financial Markets Brokerage Prop Trading Quant Tekel
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:01, il y a 1 année 6 mois

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025

Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 14:00, il y a 1 année 6 mois

CANEX Increases Equity Financing
CANEX Metals Inc. announces increase in non-brokered private placement to offer up to 3,000,000 Common Shares and 5,250,000 FT Shares for a total of $450,000. Funds to be used for exploration and project advancement

Private Placement TSX Venture Exchange Exploration CANEX Metals Inc. Shareholder Demand
COMMUNIQUÉ DE PRESSE

publié le 21/10/2024 à 13:30, il y a 1 année 6 mois

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
MIRA Pharmaceuticals, Inc. announces promising results for novel oral ketamine analog Ketamir-2 in providing superior pain relief compared to current treatments. Preparing for Phase 1 clinical trials and exploring potential in PTSD

Clinical Trials PTSD MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain

Les Echos

Publié le 15/05/2026 à 15:08, il y a 4 heures 16 minutes

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Publié le 15/05/2026 à 15:00, il y a 4 heures 24 minutes

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Publié le 15/05/2026 à 10:09, il y a 9 heures 15 minutes

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Publié le 14/05/2026 à 09:03, il y a 1 jour 10 heures

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Publié le 13/05/2026 à 18:02, il y a 2 jours 1 heure

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 15/05/2026 à 18:45, il y a 39 minutes

HELLENiQ ENERGY Holdings S.A. Announces First Quarter 2026 Financial Results
Publié le 15/05/2026 à 14:35, il y a 4 heures 49 minutes

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
Publié le 15/05/2026 à 14:30, il y a 4 heures 54 minutes

AIAI Holdings Corporation Expresses Appreciation to Revere Securities for Financial Advisory Support on Successful NASDAQ Direct Listing
Publié le 15/05/2026 à 14:00, il y a 5 heures 24 minutes

CCL Industries Announces 2026 Annual and Special Shareholders' Meeting Results
Publié le 15/05/2026 à 14:00, il y a 5 heures 24 minutes

First Canadian Graphite to Attend the Mining Investment Event in Quebec City

Voir tout ACCESSWIRE

EQS Group

Publié le 15/05/2026 à 18:30, il y a 54 minutes

Designated Person Notifications
Publié le 15/05/2026 à 18:30, il y a 54 minutes

Designated Person Notifications
Publié le 15/05/2026 à 18:10, il y a 1 heure 14 minutes

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Publié le 15/05/2026 à 17:33, il y a 1 heure 51 minutes

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Publié le 15/05/2026 à 16:48, il y a 2 heures 36 minutes

Fuller, Smith & Turner PLC: Transaction in own shares